• SM-164 and the Next Logic of Cell-Death Translation

  2026-10-06

  SM-164 is a bivalent Smac mimetic that offers translational researchers a mechanistically rich way to interrogate IAP-controlled apoptosis. This article connects vendor-reported SM-164 activity with new insights into necrosome assembly, including the reported balance between RIP1 and RIP3 that governs signal amplification and attenuation. It frames SM-164 as a research perturbation for studying cIAP-1/2, XIAP, TNFα-dependent apoptosis, caspase activation, and possible cross-talk between apoptotic and necroptotic signaling—while distinguishing established findings from testable hypotheses and identifying the limits of cell-line and xenograft evidence.

• JHU-083: Evidence, Applications, and Limitations

  2026-10-06

  JHU-083 is described as a 6-diazo-5-oxo-L-norleucine precursor for investigating glutaminase-dependent metabolism and glutamate biology. This overview separates supplier claims from published evidence, explains its conceptual relevance to experimental cerebral malaria research and glutamate excitotoxicity research, and clarifies why findings from a separate α-amanitin hepatotoxicity study should not be generalized to JHU-083.

• Lassa Virus Spike: pH Changes and Inhibition

  2026-10-05

  Katz et al. map previously unresolved pH-dependent conformational changes in the Lassa virus spike, linking early transmembrane rearrangements with later receptor release and spike opening. Their structural and functional evidence also explains how ARN-75039 antagonizes viral entry, while defining important boundaries for interpreting these findings beyond the studied system.

• TUNEL and Mitochondrial Stress in Glioblastoma

  2026-10-05

  This overview examines how terminal deoxynucleotidyl transferase (TdT) labeling can contextualize apoptosis research in glioblastoma, using a recent study of mitochondrial CAT-tailing as the biological framework. It distinguishes reported findings from interpretation, explains conceptual applications in tissue sections and cultured cells, and evaluates the strengths and limits of TUNEL-based DNA fragmentation detection. The discussion also clarifies why TUNEL positivity is not, by itself, proof of apoptosis or evidence that mitochondrial CAT-tailing directly caused a phenotype.

• Maternal IL-17A and Neonatal GBS Risk

  2026-10-03

  A prospective Moroccan mother–newborn study identifies reduced maternal IL-17A, together with lower IL-1β and IL-4 responses, among GBS-colonized women whose newborns developed invasive disease. The work supports maternal IL-17A as a potential risk-stratification biomarker while showing how cytokine profiling and pathogen-recognition receptor stimulation can connect colonization status with neonatal outcomes.

• One-step TUNEL Cy3 Apoptosis Detection Kit Guide

  2026-10-02

  Connect DNA-fragment labeling with practical apoptosis readouts in tissue sections and cultured cells. This guide translates a hepatoprotective peptide study into a controlled workflow for spatial imaging, flow cytometry, and mechanistic validation.

• CUDC-907: Practical PI3K/HDAC Workflow

  2026-10-01

  CUDC-907 is a dual PI3K and HDAC inhibitor for controlled in vitro studies of PI3K/AKT signaling, histone acetylation, cell-cycle progression, and apoptosis. This guidance uses product-dossier specifications and laboratory workflow recommendations rather than directly matched paper evidence; the compound is for research use only and not for diagnostic, clinical, or therapeutic use.

• CD44 Metabolic Rewiring in IDH-Mutant Leukemia

  2026-09-30

  The reference study identifies CD44 as a metabolic dependency of IDH-mutant leukemia, linking R-2HG-driven signaling to pentose phosphate pathway activation and sustained NADPH production. Its findings support combined metabolic and IDH-directed experiments while clarifying how CD44 may contribute to incomplete responses and resistance.

• Oseltamivir acid: Neuraminidase Workflows

  2026-09-30

  Oseltamivir acid supports mechanism-first influenza antiviral research, from purified neuraminidase assays to infection and oncology cell models. This guide combines practical assay design with a cautious translational lesson from humanized-mouse prodrug research, helping teams separate direct enzyme inhibition from exposure and metabolism effects.

• ARCA Cy3 EGFP mRNA (5-moUTP): Lab Guide

  2026-09-29

  A scenario-based guide to using ARCA Cy3 EGFP mRNA (5-moUTP), SKU R1008, to separate mRNA delivery, translation, and cell-viability effects in mammalian cell assays. The article combines product specifications with practical controls and delivery-system context from recent mRNA research.

• GPX3–JNK/c-Jun Signaling in Pancreatic Cancer

  2026-09-29

  Ma et al. identify GPX3 as a pancreatic cancer suppressor that limits proliferation, motility, epithelial–mesenchymal transition, and resistance to Gemcitabine through inhibition of JNK/c-Jun signaling. The combination of database analysis, functional assays, and anisomycin rescue experiments provides a mechanistic framework for studying GPX3 as a determinant of chemotherapy response.

• Nystatin (Fungicidin): Assay Workflows

  2026-09-28

  Build more reproducible Candida susceptibility, adhesion, and membrane-integrity assays with Nystatin (Fungicidin). This guide also shows how the reference study’s negative nystatin result can improve controls when membrane-active compounds are evaluated in nonfungal cell-entry models.

• Moxidectin–Polyenes Synergy in Oral Candidiasis

  2026-09-28

  A 2024 study reports that moxidectin increases Candida albicans ergosterol levels and enhances the activity of the polyenes amphotericin B and nystatin. The findings connect a measurable change in fungal sterol biology to improved outcomes in a mouse model of oral candidiasis, while leaving clinical efficacy and broader species coverage to be tested.

• Moxidectin Potentiates Nystatin Against Oral Candidiasis

  2026-09-27

  A 2024 study reports that moxidectin increases Candida albicans ergosterol biosynthesis, strengthening the activity of the polyenes nystatin and amphotericin B in laboratory assays and a mouse oral-candidiasis model. The findings support a target-amplification strategy for polyene combinations, while leaving dose selection, safety, and clinical benefit to be established.

• Reading mRNA Delivery Beyond GFP: From Uptake to Function

  2026-09-26

  Dual-fluorescence mRNA reporters can help researchers distinguish cellular RNA-associated signal from productive protein expression. Learn how to interpret both readouts, build more informative delivery assays, and translate formulation-screening results with appropriate controls.

8639 records 1/576 page Next 12345 下5页 Last page